Who makes CP-481,715?

CP-481,715 is developed by Pfizer.

Last reviewed 2026-04-19 · How we verify

CP-481,715

Pfizer · Phase 1 active Small molecule

At a glance

Generic name	CP-481,715
Sponsor	Pfizer
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CP-481,715 CI brief — competitive landscape report
CP-481,715 updates RSS · CI watch RSS
Pfizer portfolio CI